FDA Approves Postpartum Depression Drug That Works Within Days
August 12, 2023The first oral treatment for postpartum depression (PPD), zuranolone, has been approved by the Food and Drug Administration (FDA) and is expected to launch later this year.
The medication, brand name Zurzuvae, is taken in pill form once daily for 14 days, and improvement of symptoms may be noticed as soon as three days after beginning treatment, researchers found.The only other FDA-approved medication for PPD, brexanolone (brand name Zulresso), must be administered as a single, 60-hour IV drip in a healthcare facility.
Because of zuranolone’s quick onset of action, and the accessibility of the pill formulation, it offers the promise of much-needed help for scores of new mothers battling postpartum depression, including those with ADHD who are up to five times as likely as their neurotypical counterparts to develop PPD.In a recent press release, Tiffany R.
Read more on additudemag.com
